Skip to content
Stop using now Drug recall · FDA · Published May 8, 2014

Zydus Recalls Promethazine Tablets Due to Foreign Atenolol Mix-Up

Zydus Pharmaceuticals recalls 10,200 bottles of 25 mg Promethazine tablets due to the presence of foreign atenolol tablets. Check your lot number.

🇺🇸 FDA recall #D-1342-2014DrugZydus Pharmaceuticals ›
Take action

Contact the company

Recalling firmZydus Pharmaceuticals USA Inc73 Route 31 N · Pennington, NJ 08534-3601
✎ GovInfoNow plain-language explainer

What happened, in plain English

Zydus Pharmaceuticals USA Inc is recalling 10,200 bottles of Promethazine Hydrochloride Tablets, USP, 25 mg because they may contain foreign atenolol 25 mg tablets mixed in with the correct medication. This recall affects bottles distributed nationwide with lot number MN9081 and an expiry date of 09/2015. The record does not specify a remedy or return process for consumers. Read more at govinfonow.com/recall/46093-zydus-pharmaceuticals-usa-inc-recalls-promethazine-hydrochloride-tablets-usp-25.

Source Summary by GovInfoNow · govinfonow.com/recall/46093-zydus-pharmaceuticals-usa-inc-recalls-promethazine-hydrochloride-tablets-usp-25 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1342-2014

Cite this page

“Zydus Recalls Promethazine Tablets Due to Foreign Atenolol Mix-Up.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46093-zydus-pharmaceuticals-usa-inc-recalls-promethazine-hydrochloride-tablets-usp-25. Based on FDA recall #D-1342-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1342-2014%22&limit=1).

Why it’s dangerous

The presence of atenolol, a beta-blocker used for heart conditions, in bottles intended for promethazine, an antihistamine/antiemetic, creates a serious risk of unintended drug exposure. Taking the wrong medication can lead to adverse health effects, particularly for those sensitive to beta-blockers or those who require promethazine for its specific therapeutic effect.

Who’s affected

Patients who have been prescribed Promethazine Hydrochloride Tablets, USP, 25 mg by Zydus Pharmaceuticals USA Inc and purchased them nationwide before the recall date. Individuals with heart conditions taking atenolol are at specific risk of accidental double-dosing or incorrect medication intake.

How to tell if you have this one

Check if you have 100-tablet bottles of Promethazine Hydrochloride Tablets, USP, 25 mg, Rx Only. Look for NDC 68382-041-01 and Lot number MN9081 on the packaging. The expiry date on these bottles is 09/2015.

  • Brand
    Zydus Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop taking the medication

    Do not consume any tablets from bottles matching the recalled lot number due to the risk of ingesting foreign atenolol tablets.

  2. Contact your pharmacist or doctor

    Consult your healthcare provider for guidance on alternative treatments and how to properly dispose of the recalled product, as no specific remedy is listed in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: May 8, 201412. FDA classified it Class II: May 21, 201423. Published in FDA’s Enforcement Report: May 28, 201434. FDA terminated the recall: Feb 26, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Who manufactured and distributed these tablets?

The tablets were manufactured by Cadila Healthcared Ltd., India, and distributed by Zydus Pharmaceuticals USA Inc., Pennington, NJ.

Similar recalls

Other Zydus Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1342-2014 (May 8, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1342-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA